Denali Therapeutics, Inc. (DNLI)

18.11 +0.16 (+0.89%) USD  |  NASDAQ  |  Jan 13, 16:00
18.21 +0.10 (+0.55%) After-Hours: 06:26
More

Denali Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Enovis Corp. Upgrade
Masimo Corp. Upgrade
Novavax, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade